Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 211

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

The Role of IL‐1 β in the Bone Loss during Rheumatic Diseases

Open access
Ruscitti, Piero, Cipriani, Paola, Carubbi, Francesco, Liakouli, Vasiliki, Zazzeroni, Francesca, Di Benedetto, Paola, Berardicurti, Onorina, Alesse, Edoardo, Giacomelli, Roberto · 2015 · Mediators of Inflammation

Abstract

Several inflammatory diseases have been associated with increased bone resorption and fracture rates and different studies supported the relation between inflammatory cytokines and osteoclast activity. The main factor required for osteoclast activation is the stimulation by receptor activator of nuclear factor kappa‐B ligand (RANKL) expressed on osteoblasts. In this context, interleukin‐ (IL‐) 1 β, one of the most powerful proinflammatory cytokines, is a strong stimulator of in vitro and in vivo bone resorption via upregulation of RANKL that stimulates the osteoclastogenesis. The resulting effects lead to an imbalance in bone metabolism favouring bone resorption and osteoporosis. In this paper, we review the available literature on the role of IL‐1 β in the pathogenesis of bone loss. Furthermore, we analysed the role of IL‐1 β in bone resorption during rheumatic diseases and, when available, we reported the efficacy of anti‐IL‐1 β therapy in this field.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2015/782382

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 211

Metadata

Authors
Ruscitti, P., Cipriani, P., Carubbi, F., Liakouli, V., Zazzeroni, F., Di Benedetto, P., Berardicurti, O., Alesse, E., & Giacomelli, R.
Venue
Mediators of Inflammation
Publisher
Wiley
Published
2015-01
Volume
2015
Issue
1
Pages
782382-782382
ISSN
  • 0962-9351 (ISSN-L)
  • 1466-1861
OpenAlex
W1983588052
Cited by
211
References
5
FWCI
5.66
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.